ORCID as entered in ROS

Select Publications
2022, 'Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy', Journal of Infectious Diseases, 225, pp. 1721 - 1730, http://dx.doi.org/10.1093/infdis/jiab533
,2022, 'Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory', Nature Immunology, 23, pp. 768 - 780, http://dx.doi.org/10.1038/s41590-022-01175-5
,2022, 'Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation', The Journal of Immunology, 208, pp. 125.10 - 125.10, http://dx.doi.org/10.4049/jimmunol.208.supp.125.10
,2022, 'Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization', Nature, 602, pp. 654 - 656, http://dx.doi.org/10.1038/s41586-021-04387-1
,2022, 'Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis', Lancet Microbe, 3, pp. e52 - e61, http://dx.doi.org/10.1016/S2666-5247(21)00267-6
,2022, 'Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial', Clinical Infectious Diseases, 75, pp. e878 - e879, http://dx.doi.org/10.1093/cid/ciac075
,2022, 'SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', , http://dx.doi.org/10.21203/rs.3.rs-1207364/v1
,2021, 'mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern', Science, 374, pp. abm0829, http://dx.doi.org/10.1126/science.abm0829
,2021, 'Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19', Nature Communications, 12, pp. 1162, http://dx.doi.org/10.1038/s41467-021-21444-5
,2021, 'The mucosal barrier and anti-viral immune responses can eliminate portions of the viral population during transmission and early viral growth', Plos One, 16, pp. e0260010, http://dx.doi.org/10.1371/journal.pone.0260010
,2021, 'Validation of multiplex PCR sequencing assay of SIV', Virology Journal, 18, pp. 21, http://dx.doi.org/10.1186/s12985-020-01473-0
,2021, 'Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121', Frontiers in Immunology, 12, pp. 749891, http://dx.doi.org/10.3389/fimmu.2021.749891
,2021, 'Immune imprinting and SARS-CoV-2 vaccine design', Trends in Immunology, 42, pp. 956 - 959, http://dx.doi.org/10.1016/j.it.2021.09.001
,2021, 'Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain', Cell Reports, 37, pp. 109822, http://dx.doi.org/10.1016/j.celrep.2021.109822
,2021, 'Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection', Nature Medicine, 27, pp. 1205 - 1211, http://dx.doi.org/10.1038/s41591-021-01377-8
,2021, 'Decay of Fc-dependent antibody functions after mild to moderate COVID-19', Cell Reports Medicine, 2, pp. 100296, http://dx.doi.org/10.1016/j.xcrm.2021.100296
,2021, 'Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans', Journal of Infectious Diseases, 223, pp. 2154 - 2163, http://dx.doi.org/10.1093/infdis/jiaa678
,2021, 'Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection', Nature Reviews Immunology, 21, pp. 395 - 404, http://dx.doi.org/10.1038/s41577-021-00550-x
,2021, 'Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir', Plos Pathogens, 17, pp. e1009686, http://dx.doi.org/10.1371/journal.ppat.1009686
,2021, 'Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice', Proceedings of the National Academy of Sciences of the United States of America, 118, pp. e2101918118, http://dx.doi.org/10.1073/pnas.2101918118
,2021, 'CD8+T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification', Journal of Clinical Investigation, 131, http://dx.doi.org/10.1172/JCI141677
,2021, 'Tear antibodies to SARS-CoV-2: implications for transmission', Clinical and Translational Immunology, 10, pp. e1354, http://dx.doi.org/10.1002/cti2.1354
,2021, 'SARS-CoV-2 variants: levels of neutralisation required for protective immunity', , pp. 2021.08.11.21261876, http://dx.doi.org/10.1101/2021.08.11.21261876
,2021, 'Tear antibodies to SARS-CoV-2: implications for transmission', Clinical and Translational Immunology, pp. 2021.08.02.21261479 - 2021.08.02.21261479, http://dx.doi.org/10.1002/cti2.1354
,2021, 'Tracking the kinetics and phenotype of spike epitope-specific CD4 T cell immunity in the context of SARS-CoV-2 infection and vaccination', , http://dx.doi.org/10.21203/rs.3.rs-957030/v1
,2021, 'What level of neutralising antibody protects from COVID-19?', , pp. 2021.03.09.21252641, http://dx.doi.org/10.1101/2021.03.09.21252641
,2020, 'Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models', Nature Reviews Immunology, 20, pp. 727 - 738, http://dx.doi.org/10.1038/s41577-020-00471-1
,2020, 'Transcriptome dynamics of CD4+ T cells during malaria maps gradual transit from effector to memory.', Nature Immunology, 21, pp. 1597 - 1610, http://dx.doi.org/10.1038/s41590-020-0800-8
,2020, 'Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood', ACS Nano, 14, pp. 15723 - 15737, http://dx.doi.org/10.1021/acsnano.0c06679
,2020, 'Artemisinin Resistance and the Unique Selection Pressure of a Short-acting Antimalarial', Trends in Parasitology, 36, pp. 884 - 887, http://dx.doi.org/10.1016/j.pt.2020.07.004
,2020, 'Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19', Nature Medicine, 26, pp. 1428 - 1434, http://dx.doi.org/10.1038/s41591-020-0995-0
,2020, 'Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption', Proceedings of the Royal Society B: Biological Sciences, 287, pp. 20200354, http://dx.doi.org/10.1098/rspb.2020.0354
,2020, 'Building a T cell compartment: how immune cell development shapes function', Nature Reviews Immunology, 20, pp. 499 - 506, http://dx.doi.org/10.1038/s41577-020-0332-3
,2020, 'Quantifying and preventing plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil', Plos Neglected Tropical Diseases, 14, pp. 1 - 16, http://dx.doi.org/10.1371/journal.pntd.0008526
,2020, 'Malaria Parasite Clearance: What Are We Really Measuring?', Trends in Parasitology, 36, pp. 413 - 426, http://dx.doi.org/10.1016/j.pt.2020.02.005
,2020, 'Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults', Vaccine, 38, pp. 2368 - 2377, http://dx.doi.org/10.1016/j.vaccine.2020.01.066
,2020, 'Genetically barcoded SIV reveals the emergence of escape mutations in multiple viral lineages during immune escape', Proceedings of the National Academy of Sciences of the United States of America, 117, pp. 494 - 502, http://dx.doi.org/10.1073/pnas.1914967117
,2020, 'In vivo validation of the viral barcoding of simian immunodeficiency virus SIVmac239 and the development of new barcoded SIV and subtype B and C simian-human immunodeficiency viruses', Journal of Virology, 94, pp. 10.1128/jvi.01420 - 10.1128/jvi.01419, http://dx.doi.org/10.1128/JVI.01420-19
,2020, 'Stochastic expansions maintain the clonal stability of CD8+ T cell populations undergoing memory inflation driven by murine cytomegalovirus', Journal of Immunology, 204, pp. 112 - 121, http://dx.doi.org/10.4049/jimmunol.1900455
,2019, 'Predictors of SIV recrudescence following antiretroviral treatment interruption', Elife, 8, pp. e49022, http://dx.doi.org/10.7554/eLife.49022
,2019, 'The peripheral differentiation of human natural killer T cells', Immunology and Cell Biology, 97, pp. 586 - 596, http://dx.doi.org/10.1111/imcb.12248
,2019, 'Corrigendum: Defining the effectiveness of antimalarial chemotherapy: Investigation of the lag in parasite clearance following drug administration (Journal of Infectious Diseases (2016) 214 (753-761) DOI: 10.1093/infdis/jiw234)', Journal of Infectious Diseases, 219, pp. 1852 - 1853, http://dx.doi.org/10.1093/infdis/jiy729
,2019, 'Moving the HIV vaccine field forward: concepts of protective immunity', Lancet HIV, 6, pp. e406 - e410, http://dx.doi.org/10.1016/S2352-3018(19)30134-1
,2019, 'Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells', Plos Pathogens, 15, pp. e1007599, http://dx.doi.org/10.1371/journal.ppat.1007599
,2019, 'Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants', Malaria Journal, 18, pp. 19, http://dx.doi.org/10.1186/s12936-019-2657-6
,2019, 'Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques', Journal of Clinical Investigation, 129, pp. 182 - 191, http://dx.doi.org/10.1172/JCI122466
,2019, 'Defining early SIV replication and dissemination dynamics following vaginal transmission', Science Advances, 5, pp. eaav7116, http://dx.doi.org/10.1126/sciadv.aav7116
,2019, 'Fate mapping reveals the age structure of the peripheral T cell compartment', Proceedings of the National Academy of Sciences of the United States of America, 116, pp. 3974 - 3981, http://dx.doi.org/10.1073/pnas.1811634116
,2019, 'Functional cure of HIV: the scale of the challenge', Nature Reviews Immunology, 19, pp. 45 - 54, http://dx.doi.org/10.1038/s41577-018-0085-4
,2019, 'Novel RNA viruses associated with Plasmodium vivax in human malaria and Leucocytozoon parasites in avian disease', Plos Pathogens, 15, pp. e1008216, http://dx.doi.org/10.1371/journal.ppat.1008216
,